PFG Investments LLC boosted its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the Securities ...
“Case outcomes (settlement, plaintiff or defendant ruling) did not statistically vary based on the SCS (spinal cord stimulator) manufacturer type-St. Jude, Boston Scientific Corp., or Medtroni ...
A range of spinal cord stimulators have been approved by the FDA, but none specifically for SCI patients. Abbott, Medtronic and Boston Scientific all have products indicated for chronic pain.
Accurate Wealth Management LLC acquired a new stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) during the ...
Hosted on MSN14d
M&A Synergies Drive BSX: Is it Worth Buying the Stock Now?Despite macroeconomic concerns, currency headwinds and related cost inflation, Boston Scientific Corporation BSX is seeing strength across target markets. The company is demonstrating growth backed by ...
The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...
Boston Scientific Corporation develops ... neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback